Finch Therapeutics Group's market cap is currently $21.60M. The company's EPS TTM is $-8.823; its P/E ratio is -1.52; Finch Therapeutics Group is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23
Dec 22
Dec 21
Dec 20
Dec 19
Currency in USD
Finch Therapeutics Group Earnings and Revenue History
